Competitive Ligand-Binding Assays for the Detection of Neutralizing Antibodies

Detection and Quantification of Antibodies to Biopharmaceuticals: Practical and Applied Considerations

Volumn , Issue , 2011, Pages 175-192

  Wu, Bonnie W ^a   Gunn, George R ^a   Shankar, Gopi ^a  

^a CENTOCOR INC   (United States)

Author keywords

Cell based bioassays, assay format non cell based CLBAs, as ECL based NAb assays; Cell based NAb bioassays, in vitro functional assays cell lines, drug assessed for NAbs; Competitive ligand binding assays for detection of neutralizing antibodies

Indexed keywords

EID: 80052505414     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118075685.ch10     Document Type: Chapter

References (25)

1. Schellekens, H. ( 2002 ). Immunogenicity of therapeutic proteins: clinical implications and future prospects . Clin Ther, 24, 1720-1740 .
2. Rosenberg, A.S., Worobec, A. ( 2004 ). A risk-based approach to immunogenicity concerns of therapeutic protein products. Part 1. Considering consequences of the immune response to a protein . Biopharm Int, 17, 22-26 .
3. Pendley, C., Schantz, A., Wagner, C. ( 2003 ). Immunogenicity of therapeutic monoclonal antibodies . Curr Opin Mol Ther, 5, 172-179 .
4. Gupta, S., Indelicato, S.R., Jethwa, V., Kawabata, T., Kelly, M., Anthony R., Mire-Sluis, A.R., Richards, S.M., Rup, B., Shores, E., Swanson, S.J., Wakshull, E. ( 2007 ). Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics . J Immunol Methods, 321, 1-18 .
5. Benoit, P., Maguire, D., Plavec, I., Kocher, H., Tovey, M., Meyer, F. ( 1993 ). A monoclonal antibody to recombinant human IFN-cx receptor inhibits biologic activity of several species of human IFN-a, IFN-β, and IFN-? . J Immunol, 150 ( 3 ), 707-716 .
6. Schellekens, H., Casadevall, N. ( 2004 ). Immunogenicity of recombinant human proteins: causes and consequences . J Neurol, 251 ( Suppl. 2 ), II/4-II/9 .
7. Green, D. ( 2000 ). Spontaneous inhibitors to coagulation factors . Clin Lab Haematol, 22 ( Suppl. 1 ), 21-25 .
8. Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., Varet, B., Mayeux, P. ( 2002 ). Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin . N Engl J Med, 346, 469-475 .
9. Li, J., Yang, C., Xia, Y., Bertino, A., Glaspy, J., Roberts, M., Kuter, D.J. ( 2001 ). Thrombocytopenia caused by the development of antibodies to thrombopoietin . Blood, 98, 3241-3248 .
10. Wadhwa, M., Bird, C., Dilger, P., Gaines-Das, R., Thorpe, R. ( 2003 ). Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals . J Immunol Methods, 278, 1-17 .
11. Koren, E., Smith, H.W., Shores, E., Shankar, G., Finco-Kent, D., Rup, B., Barret, Y.C., Devanarayan, V., Gorovits, B., Gupta, S., Parish, T., Quanmby, V., Moxness, M., Swanson, S.J., Taniguchi, G., Zuckerman, L.A., Stebbins, C.C., Mire-Sluis, A. ( 2008 ). Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products . J Immunol Methods, 333, 1-9 .
12. Mire-Sluis, A.R., Barrett, Y.C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., Swanson, S.J., Taniguchi, G., Wierda, D., Zuckerman, L.A. ( 2004 ). Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products . J Immunol Methods, 289, 1-16 .
13. Thorpe, R., Swanson, S.J. ( 2005 ). Current methods for detecting antibodies against erythropoietin and other recombinant proteins . Clin Diagn Lab Immunol, 12, 28-39 .
14. Wadhwa, M., Thorpe, R. ( 2008 ). Assessment of unwanted immunogenicity . In Immunogenicity of Biopharmaceuticals . van de Weert M, Moller EH, eds. Springer, New York, pp. 57-73 .
15. Lu, Y., Wong, W.L., Meng, Y.G. ( 2006 ). A high throughput electrochemiluminescent cell-binding assay for therapeutic anti-CD20 antibody selection . J Immunol Methods, 314, 74-79 .
16. Liang, P., Sanchez, R.I., Martin, M.T. ( 1996 ). Electrochemiluminescence-based detection of beta-lactam antibiotics and beta-lactamases . Anal Chem, 68, 2426-2431 .
17. Yang, H., Leland, J.K., Yost, D., Massey, R.J. ( 1994 ). Electrochemiluminescence: a new diagnostic and research tool. ECL detection technology promises scientists new " yardsticks " for quantification . Biotechnology (NY), 12, 193-194 .
18. Liang, M., Klakamp, S.L., Funelas, C., Lu, H., Lam, B., Herl, C., Umble, A., Drake, A.W., Pak, M., Ageyeva, N., Pasumarthi, R., Roskos, L.K. ( 2007 ). Detection of high-and low-affinity antibodies against a human monoclonal antibody using various technology platforms . Assay Drug Dev Technol, 5, 655-662 .
19. Shankar, G., Pendley, C., Stein, K.E. ( 2007 ). A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs . Nat Biotechnol, 25, 555-561 .
20. Gupta, S. ( 2005 ). Design and validation of a non-cell-based receptor binding assay for the detection of neutralizing antibodies to a biological therapeutic. IIR Immunogenicity Meeting.
21. Herzenberg, L.A., De Rosa, S.C. ( 2000 ). Monoclonal antibodies and the FACS: complementary tools for immunobiology and medicine . Immunol Today, 21, 383-390 .
22. Sedgwick, J.D., Czerkinsky, C. ( 1992 ). Detection of cell-surface molecules, secreted products of single cells and cellular proliferation by enzyme immunoassay . J Immunol Methods 150, 159-175 .
23. Loyet, K.M., Deng, R., Laing, W.C., Wu, Y., Lowman, H.B., DeForge, L.E. ( 2009 ). Technology comparisons for anti-therapeutic antibody and neutralizing antibody assays in the context of an anti-TNF pharmacokinetic study . J Immunol Methods, 345, 17-28 .
24. Shankar, G., Devanaryan, V., Amaravadi, L., Barret, Y.C., Bowsher, R., Finco-Kent, D., Fischella, M., Gorovits, B., Kirschner, S., Moxness, M., Parish, T., Quarmby, V., Smith, H., Smith, W., Zuckerman, L.A., Koren, E. ( 2008 ). Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products . J Pharm Biomed Anal, 48, 1267-1281 .
25. Geng, D., Shankar, G., Schantz, A., Rajadhyaksha, M., Davis, H., Wagner, C. ( 2005 ). Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies . J Pharm Biomed Anal, 39, 364-375 .